News | May 08, 2023
Galmed Pharmaceuticals forms partnership with OnKai
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
To create leading company developing medicines targeting metalloenzymes
The receipt of this permission paves way for the launch of Dapagliflozin (Forxiga) tablets of 10 mg in India for the specified additional/expanded indication, subject to the receipt of related statutory approvals
NFIL’s ambition is to reach revenues of US$100mn from CDMO by FY25.
Kokilaben Hospital is also the first hospital in Navi Mumbai to receive the SMART ICU certification
Coordinated by the Medical University of Vienna, a consortium of 13 leading European organizations including university hospitals, research institutions and healthcare companies will conduct the 5-year project co-funded by Horizon Europe.
The agreement sharpens the company’s focus on priority medicines in respiratory & immunology portfolio
Acute therapies continue to report strong growth compared to chronic ones.
The three-dose vaccine approved for EUA contains 2mg for each dose, whereas the two-dose plan will have 3mg in each dose.
Subscribe To Our Newsletter & Stay Updated
